Exciting Instruments appoints chairman

Exciting Instruments Ltd, a developer of technology to accelerate drug discovery, has appointed Jonathan Rigby as chairman. Mr Rigby brings extensive experience in building and financing life sciences companies including SteadyMed Therapeutics, acquired by United Therapeutics, and co-founding Zogenix Inc, which was acquired by UCB Pharma for $2 billion. He is currently chairman and chief executive officer of Sernova, a regenerative medicine company.

Exciting Instruments’ benchtop single-molecule detection platform is designed to accelerate and improve the discovery of novel proteins and drug candidates. Mr Rigby will support the UK company’s expansion and partnerships strategy with academic researchers and pharmaceutical companies.

Exciting Instruments announced the appointment on 25 September 2025.